| Naslov: | Clinical pharmacy services in mental health in Europe : a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health |
|---|
| Avtorji: | ID Štuhec, Matej (Avtor)
ID Hahn, Martina (Avtor)
ID Taskova, I. (Avtor)
ID Bayraktar, I. (Avtor)
ID Fitzgerald, I. (Avtor)
ID Molitschnig, L. (Avtor)
ID Tatarević, A. (Avtor)
ID Lindner, N. (Avtor)
ID Agnoletto, L. (Avtor)
ID da Costa, Filipa Alves (Avtor) |
|---|
| Datoteke: |  Stuhec-2023-Clinical_pharmacy_services_in_ment.pdf (404,08 KB)
MD5: 8B28FF1772E1CE27A4E9A581DC5CCDAB
 https://doi.org/10.1007/s11096-023-01643-4
|
|---|
| Jezik: | Angleški jezik |
|---|
| Vrsta gradiva: | Znanstveno delo |
|---|
| Tipologija: | 1.02 - Pregledni znanstveni članek |
|---|
| Organizacija: | MF - Medicinska fakulteta
|
|---|
| Opis: | A large proportion of the world's disease burden is attributable to mental illnesses. Although effective interventions are available, many patients still have limited access to evidence-based treatments. Aside from access, treatment gaps, including inappropriate medication selection and monitoring, are also routinely recognised. Mental health clinical pharmacists can help address these gaps and enable patients to receive optimised pharmaceutical care, particularly appropriate medication selection and monitoring. The European Society of Clinical Pharmacy (ESCP) Special Interest Group on Mental Health was established to improve standardised service provision in mental health settings across Europe. The Special Interest Group identified significant barriers (predominantly associated with reimbursement and position within the multidisciplinary team) to effective pharmaceutical care amongst those with mental illnesses. This commentary presents recommendations to address these gaps through improved mental health clinical pharmacy service provision. |
|---|
| Ključne besede: | clinical pharmacist interventions, clinical pharmacy in mental health, European society of clinical pharmacy, mental illnesses and pharmacy, pharmaceutical services in mental health, polypharmacy and clinical pharmacy, psychotropics and clinical pharmacy |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Poslano v recenzijo: | 29.05.2023 |
|---|
| Datum sprejetja članka: | 25.08.2023 |
|---|
| Datum objave: | 27.09.2023 |
|---|
| Založnik: | Springer Nature |
|---|
| Leto izida: | 2023 |
|---|
| Št. strani: | Str. 1286-1292 |
|---|
| Številčenje: | Letn. 45, Št. 5 |
|---|
| PID: | 20.500.12556/DKUM-88319  |
|---|
| UDK: | 615.2:616.89 |
|---|
| COBISS.SI-ID: | 188461315 |
|---|
| DOI: | 10.1007/s11096-023-01643-4doi |
|---|
| ISSN pri članku: | 2210-7711 |
|---|
| Datum objave v DKUM: | 15.04.2024 |
|---|
| Število ogledov: | 351 |
|---|
| Število prenosov: | 28 |
|---|
| Metapodatki: |    |
|---|
| Področja: | Ostalo
|
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Skupna ocena: | (0 glasov) |
|---|
| Vaša ocena: | Ocenjevanje je dovoljeno samo prijavljenim uporabnikom. |
|---|
| Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
